Now Playing
Mucosal Immunity, IgG4 Shifts & AI Vaccine Design | Ep. 1
Audio is available on Spreaker — see link below.
A new immunological review explains precisely why COVID boosters protect against severe disease but don't stop infection — and what that means for vaccine strategy. Today's briefing also covers AI-designed self-adapting mRNA vaccines, cancer splicing targets, ocean heat load, and a structural shift in solar energy markets.
Audio is available on Spreaker — see link below.
Boosters reduce your risk of ending up in hospital. They don't reliably stop you from getting infected.
There's a second thread in this picture worth tracking, though it requires careful framing. Repeated mRNA vaccination produces a reproducible shift in some people toward IgG4 antibodies, a particular antibody subclass associated in other contexts with tolerance rather than aggressive immune response.
On boosters themselves, the strategic picture has shifted. New data now supports a risk-stratified approach over the universal booster model.
Stepping back from the immunity question, the mRNA platform itself is moving fast. Scientists have now used AI to design what's described as the first self-adapting mRNA vaccine, one capable of detecting viral mutations before they become dominant in circulation.
mRNA biology is also opening new fronts in oncology. New research shows that alternative splicing and RNA modifications control how immune cells recognize and attack tumors.
Two broader signals round out today's picture. Oceans currently absorb around ninety percent of excess greenhouse heat, and that buffering capacity is under compounding pressure from acidification, warming, and pollution.
Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.